Collaborative Arrangement, Collaborator's Revenue and Expense Ownership Percentage

No definition available.

Name:	pfe_CollaborativeArrangementCollaboratorsRevenueandExpenseOwnershipPercentage
Namespace Prefix:	pfe_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Company's Revenue and Expense Ownership Percentage

+ References

No definition available.

+ Details

Name:	pfe_CollaborativeArrangementCompanysRevenueandExpenseOwnershipPercentage
Namespace Prefix:	pfe_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Deferred Milestone Payment

+ References

No definition available.

+ Details

Name:	pfe_CollaborativeArrangementDeferredMilestonePayment
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Deferred Milestone Revenue Recognized

+ References

No definition available.

+ Details

Name:	pfe_CollaborativeArrangementDeferredMilestoneRevenueRecognized
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Arrangement, Milestone Payment, Receivable

+ References

No definition available.

+ Details

Name:	pfe_CollaborativeArrangementMilestonePaymentReceivable
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of the cumulative effect on retained earnings before related income tax effect.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 50
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68078379&loc=d3e122869-111746

+ Details

Name:	us-gaap_CumulativeEffectOnRetainedEarningsBeforeTax1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Cash received from collaborators during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromCollaborators
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=pfe_MerckMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=pfe_EliLillyCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BalanceSheetLocationAxis=pfe_DeferredRevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Acquisition, Divestitures, Licensing Arrangements, Collaborative Arrangements and Privately Held Investment - Collaboration Arrangement (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended	12 Months Ended
	Jan. 01, 2018	Apr. 01, 2018	Apr. 02, 2017	Sep. 30, 2018	Dec. 31, 2013	Dec. 31, 2017
Merck [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Collaborator's revenue and expense ownership percentage				60.00%
Company's revenue and expense ownership percentage				40.00%
Upfront payments received				$ 40
Eli Lilly & Company [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone revenue recognized				33
Other (Income)/Deductions, Net [Member] \| Merck [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payments received			$ 90
Milestone payment receivable		$ 40				$ 60
Deferred milestone revenue recognized		90
Other Noncurrent Liabilities [Member] \| Merck [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone payment						$ 60
Other Noncurrent Liabilities [Member] \| Eli Lilly & Company [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone revenue recognized				9
Deferred Revenue [Member] \| Eli Lilly & Company [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payments received					$ 200
Other Current Liabilities [Member] \| Eli Lilly & Company [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone revenue recognized				$ 24
Revenues [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Cumulative effect adjustment to retained earnings, pre-tax	$ 584	584
Revenues [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member] \| Other (Income)/Deductions, Net [Member] \| Merck [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone revenue recognized		85
Revenues [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member] \| Other Noncurrent Liabilities [Member] \| Merck [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone payment		60
Revenues [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member] \| Deferred Revenue [Member] \| Eli Lilly & Company [Member] \| Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Deferred milestone revenue recognized		$ 107